Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1X.
暂无分享，去创建一个
H. Zetterberg | I. Sargiannidou | K. Kleopa | A. Kagiava | M. Reilly | A. Heslegrave | J. Richter | C. Tryfonos | C. Christodoulou | A. Rossor | C. Karaiskos